Drug Makers Duke It Out Over Smallpox Vaccine Patent

Law360, New York (August 22, 2005, 12:00 AM EDT) -- The U.S. government’s desire to protect citizens from a biological terrorist attack has triggered patent litigation between two European drug makers, both leading producers of smallpox vaccinations.

Denmark-based Bavarian Nordic and United Kingdom-based Acambis Inc. are the only two companies working on a specially-weakened, hence safer, version of the smallpox vaccine. Bavarian alleges Acambis is producing its version of the weakened vaccine with stolen research, taking its complaint to the U.S. International Trade Commission Friday.

Bavarian also filed a trade secrets suit in U.S. District Court...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.